These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2814364)

  • 1. Comparison of the gastrointestinal side effects of naproxen formulated as plain tablets, enteric-coated tablets, or enteric-coated granules in capsules.
    Aabakken L; Bjørnbeth BA; Hofstad B; Olaussen B; Larsen S; Osnes M
    Scand J Gastroenterol Suppl; 1989; 163():65-73. PubMed ID: 2814364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic findings in the stomach and duodenum after treatment with enteric-coated and plain naproxen tablets in healthy subjects.
    Oddsson E; Gudjonsson H; Thjodleifsson B
    Scand J Gastroenterol; 1990 Mar; 25(3):231-4. PubMed ID: 2181621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naproxen-associated gastroduodenal toxicity: enteric coated granules versus plain tablets.
    Aabakken L; Ugstad M; Gamst ON; Winther R; Osnes M
    Eur J Rheumatol Inflamm; 1992; 12(2):43-8. PubMed ID: 1364939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteric coated naproxen tablets.
    Gamst ON
    Eur J Rheumatol Inflamm; 1992; 12(2):5-8. PubMed ID: 1364940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NSAID-associated gastrointestinal damage: methodological considerations and a review of the experience with enteric coated naproxen.
    Aabakken L
    Eur J Rheumatol Inflamm; 1992; 12(2):9-20. PubMed ID: 1364941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroscopic findings after treatment with enteric-coated and plain naproxen tablets in healthy subjects.
    Trondstad RI; Aadland E; Holler T; Olaussen B
    Scand J Gastroenterol; 1985 Mar; 20(2):239-42. PubMed ID: 3887555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroduodenal lesions associated with two different piroxicam formulations. An endoscopic comparison.
    Aabakken L; Olaussen B; Mowinckel P; Osnes M
    Scand J Gastroenterol; 1992 Dec; 27(12):1049-54. PubMed ID: 1475622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteric-coated and plain naproxen tablets in osteoarthritis; tolerability and efficacy.
    Lehn OF; Jensen ON; Andersen LA; Christensen KA; Solheim L; Barslev J; Mjølstad W; Wiig G; Ibfelt HH; Kjønniksen T
    Eur J Rheumatol Inflamm; 1992; 12(2):31-6. PubMed ID: 1364936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cimetidine tablets or suspension for the prevention of gastrointestinal mucosal lesions caused by non-steroidal, anti-inflammatory drugs.
    Aabakken L; Larsen S; Osnes M
    Scand J Rheumatol; 1989; 18(6):369-75. PubMed ID: 2515594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an enteric-coated naproxen pellet formulation.
    Hardy JG; Lamont GL; Evans DF; Haga AK; Gamst ON
    Aliment Pharmacol Ther; 1991 Feb; 5(1):69-75. PubMed ID: 1932483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sucralfate for prevention of naproxen-induced mucosal lesions in the proximal and distal gastrointestinal tract.
    Aabakken L; Larsen S; Osnes M
    Scand J Rheumatol; 1989; 18(6):361-8. PubMed ID: 2515593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy.
    Wilding IR; Hardy JG; Sparrow RA; Davis SS; Daly PB; English JR
    Pharm Res; 1992 Nov; 9(11):1436-41. PubMed ID: 1475230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of enteric-coated aspirin granules with plain and buffered aspirin: a report of two studies.
    Petroski D
    Am J Gastroenterol; 1986 Jan; 81(1):26-8. PubMed ID: 3942122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral naproxen formulations.
    Gamst ON
    Scand J Gastroenterol Suppl; 1989; 163():44-7. PubMed ID: 2814363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulations.
    Huskisson EC; Bernstein RM; Coppock JS; Davies PG; Doyle DV; Platt PR; Scott DL; Witherington RH; Wojtulewski JA
    Eur J Rheumatol Inflamm; 1992; 12(2):27-30. PubMed ID: 1364935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and relative bioavailability of a fixed-dose combination of enteric-coated naproxen and non-enteric-coated esomeprazole magnesium.
    Wang-Smith L; Fort J; Zhang Y; Sostek M
    J Clin Pharmacol; 2012 May; 52(5):670-80. PubMed ID: 21628602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morning stiffness and nightime pain in ankylosing spondylitis. A comparison between enteric-coated and plain naproxen tablets.
    Johnsen V; Brun JG; Fjeld E; Hansen K; Sydnes OA; Ugstad MB
    Eur J Rheumatol Inflamm; 1992; 12(2):37-42. PubMed ID: 1364937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and tolerability of enteric and non-enteric coated naproxen tablets: a double-blind study in patients with osteoarthritis.
    Khong TK; Downing ME; Ellis R; Patchett I; Trayner J; Miller AJ
    Curr Med Res Opin; 1991; 12(8):540-6. PubMed ID: 1764957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroduodenal lesions induced by naproxen. An endoscopic evaluation of regional differences and natural course.
    Aabakken L; Osnes M
    Scand J Gastroenterol; 1990 Dec; 25(12):1215-22. PubMed ID: 2274742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of morning stiffness in rheumatic patients after medication with enteric-coated and plain naproxen tablets.
    Johnsen V; Bjerkhoel F; Bjørneboe O; Børresen B; Finstad R; Hansen K; Moen F
    Scand J Rheumatol; 1986; 15(1):37-40. PubMed ID: 3515526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.